Xianjin Wang
Papers
6
Total Citations
385
H-Index
6
About
Xianjin Wang is a prominent urological surgeon and researcher whose work has significantly advanced the understanding and clinical adoption of robotic and minimally invasive surgical techniques. His research focuses primarily on comparative surgical oncology, with an emphasis on robot-assisted procedures for urological cancers including renal cell carcinoma, bladder cancer, and prostate cancer. Wang's most impactful contribution is his 2016 systematic review and meta-analysis comparing robot-assisted partial nephrectomy (RAPN) with open partial nephrectomy, which has garnered 139 citations and helped clarify perioperative advantages of the robotic approach. Complementing this, his earlier 2013 meta-analysis (72 citations) benchmarked RAPN against laparoscopic partial nephrectomy, while a 2015 systematic review (71 citations) critically evaluated robotic versus open radical cystectomy. Together, these studies have provided surgeons worldwide with high-level evidence to guide treatment decisions. Beyond comparative analyses, Wang has explored nuanced clinical contexts, including the impact of obesity on robotic prostatectomy outcomes and the feasibility of robotic resection for rare retroperitoneal paragangliomas — contributing pioneering early experience from China. His body of work, spanning over 385 cumulative citations, makes him an essential reference for researchers and clinicians navigating the evolving landscape of robotic urology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6